Romidepsin is a natural product derived from the bacterium *Chromobacterium violaceum*. It is a cyclic peptide with potent antitumor activity and is classified as a histone deacetylase inhibitor (HDACi). This compound has been approved for the treatment of certain types of cancer, including cutaneous T-cell lymphoma (CTCL).
